https://www.scmp.com/rss/522366/feed The US Food and Drug Administration (FDA) is a prominent US federal governmental regulatory agency, headquartered in Silver Spring, Maryland. Its primary mission is to protect public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, and the nation’s food supply, alongside cosmetics and radiation-emitting products. Established in 1906, the FDA’s key activities include regulating manufacturing, approving new medical products,... en https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png https://www.scmp.com Julie Zhang,Daniel Ren Julie Zhang,Daniel Ren Biotech firm Hangzhou Diagens Biotechnology is banking on artificial intelligence-powered chromosome testing to drive profit growth following its Hong Kong listing, as China’s falling fertility rate spurs demand for assisted reproduction. “In China, many young people do not want to marry or have children, and by the time they decide to start a family, they need medical help to do so,” said Diagens’ founder and executive director Song Ning. “We are meeting an increasing number of couples every... https://www.scmp.com/business/banking-finance/article/3348335/chinese-company-use-ai-powered-chromosome-testing-boost-profits-and-fast-track-ivf?utm_source=rss_feed https://www.scmp.com/business/banking-finance/article/3348335/chinese-company-use-ai-powered-chromosome-testing-boost-profits-and-fast-track-ivf?utm_source=rss_feed Mon, 30 Mar 2026 02:45:34 +0000 Chloe Loung Chloe Loung This series is based on our reporting on TCM: its history, treatments and growing acceptance around the world. This is the seventh instalment. In the world of traditional Chinese medicine (TCM), few remedies carry the legendary status – or the hefty price tag – of Angong Niuhuang Wan, often referred to as the “miracle pill”. The old formula, consisting of 11 herbs and minerals, has long been revered as a top-grade emergency medicine, historically used to treat those who have had a stroke or may... https://www.scmp.com/lifestyle/health-wellness/article/3344680/how-tcms-miracle-pill-used-treat-strokes-experts-urge-caution?utm_source=rss_feed https://www.scmp.com/lifestyle/health-wellness/article/3344680/how-tcms-miracle-pill-used-treat-strokes-experts-urge-caution?utm_source=rss_feed Sat, 28 Feb 2026 23:15:08 +0000 Associated Press Associated Press Powdered whole milk used to make ByHeart infant formula could be a source of contamination that led to an outbreak of botulism that has sickened dozens of babies, according to US health officials. Testing by the US Food and Drug Administration (FDA) found the type of bacteria that could cause the illness in two samples linked to the formula, officials said on Friday. The agency found that bacteria in an unopened tin of formula matched a sample from a sick baby. It also matched contamination... https://www.scmp.com/news/world/united-states-canada/article/3341080/contaminated-milk-powder-likely-source-byheart-baby-formula-botulism-outbreak-fda?utm_source=rss_feed https://www.scmp.com/news/world/united-states-canada/article/3341080/contaminated-milk-powder-likely-source-byheart-baby-formula-botulism-outbreak-fda?utm_source=rss_feed Sat, 24 Jan 2026 01:10:49 +0000 Reuters Reuters Many patients using highly effective GLP-1 drugs may not regain lost weight quickly when they stop treatment, ‌according to an analysis of real-world data that sheds light on a chief concern about the therapies. Among thousands of patients treated at a ‍large network of academic medical clinics in the United States, most had kept the weight off or lost even more 18 months after stopping semaglutide, sold by Novo Nordisk as Ozempic and Wegovy, or tirzepatide, sold by Eli Lilly as Mounjaro and... https://www.scmp.com/lifestyle/health-wellness/article/3340941/stopping-glp-1-drugs-ozempic-often-does-not-mean-weight-regain-us-research-suggests?utm_source=rss_feed https://www.scmp.com/lifestyle/health-wellness/article/3340941/stopping-glp-1-drugs-ozempic-often-does-not-mean-weight-regain-us-research-suggests?utm_source=rss_feed Fri, 23 Jan 2026 13:15:07 +0000 Victoria Bela Victoria Bela A China-led team has built the world’s first mini-womb on a chip that can fully replicate the “invasion” of human embryos in the uterus during early pregnancy. Their 3D model on a microfluidic chip can be used to uncover the mysteries behind human embryo implantation and lead to personalised treatments for women struggling to get pregnant. The team led by researchers from the Chinese Academy of Sciences Institute of Zoology said that while achieving a better understanding of human implantation... https://www.scmp.com/news/china/science/article/3339247/china-led-team-replicates-human-embryo-invasion-womb-first-time?utm_source=rss_feed https://www.scmp.com/news/china/science/article/3339247/china-led-team-replicates-human-embryo-invasion-womb-first-time?utm_source=rss_feed Sat, 10 Jan 2026 04:00:20 +0000 Associated Press Associated Press Health tech gadgets displayed at the annual CES trade show make a lot of promises. A smart scale promoted a healthier lifestyle by scanning your feet to track your heart health, and an egg-shaped hormone tracker uses artificial intelligence to help you figure out the best time to conceive. Technology and health experts, however, question the accuracy of products like these and warn of data privacy issues – especially as the US federal government eases up on regulation. The US Food and Drug... https://www.scmp.com/tech/tech-trends/article/3339151/dose-uncertainty-experts-wary-ai-health-tech-gadgets-display-ces-trade-show?utm_source=rss_feed https://www.scmp.com/tech/tech-trends/article/3339151/dose-uncertainty-experts-wary-ai-health-tech-gadgets-display-ces-trade-show?utm_source=rss_feed Thu, 08 Jan 2026 06:34:32 +0000 Victoria Bela Victoria Bela China’s biopharmaceutical sector is said to have entered an “innovation 2.0” phase as it moves to a commercialisation mindset that could see it sideline global competitors and outpace the US – despite restrictive trade policies. In recent years, innovative drug development in the world’s second-largest pharmaceutical market has rapidly approached – and in some cases surpassed – that of the United States, the world’s biggest market. Growing concerns over China’s biotech capabilities have led the... https://www.scmp.com/news/china/science/article/3338481/chinas-biopharma-sector-prime-position-challenge-us-leadership?utm_source=rss_feed https://www.scmp.com/news/china/science/article/3338481/chinas-biopharma-sector-prime-position-challenge-us-leadership?utm_source=rss_feed Fri, 02 Jan 2026 22:00:15 +0000 Associated Press Associated Press US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The US Food and Drug Administration’s approval handed drug maker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly’s oral drug, orforglipron, was still under review. Both pills are GLP-1 drugs that work like widely used injectables to mimic a natural hormone that controls appetite and feelings of... https://www.scmp.com/news/world/united-states-canada/article/3337435/no-need-needles-us-approves-wegovy-pill-weight-loss?utm_source=rss_feed https://www.scmp.com/news/world/united-states-canada/article/3337435/no-need-needles-us-approves-wegovy-pill-weight-loss?utm_source=rss_feed Tue, 23 Dec 2025 04:55:15 +0000 Associated Press Associated Press Indonesian authorities on Thursday named a Chinese executive of a metal smelting company as a suspect in a caesium-137 contamination case that resulted in the recall of some exports to the US. Lin Jingzhang, who is a director of PT Peter Metal Technology (PMT), has been designated as a suspect, Bara Hasibuan, a spokesperson for the investigating task force, said. “The Certain Crimes Directorate of the Indonesian National Police’s Criminal Investigation Unit has named Lin Jingzhang, a citizen of... https://www.scmp.com/news/asia/southeast-asia/article/3335242/chinese-executive-named-suspect-indonesian-caesium-137-contamination-case?utm_source=rss_feed https://www.scmp.com/news/asia/southeast-asia/article/3335242/chinese-executive-named-suspect-indonesian-caesium-137-contamination-case?utm_source=rss_feed Thu, 04 Dec 2025 14:06:31 +0000 Kamala Thiagarajan Kamala Thiagarajan China’s pharmaceutical industry is on the brink of enormous growth and transformation. In just a few years, it has moved on from being the world’s cheapest source of active pharmaceutical ingredients to becoming a major hub for pharmaceutical innovation – a place where new, more effective drugs are born. It is now the second-largest developer of drugs, trailing only the United States. In the global drug development pipeline, China’s growth rate is phenomenal, leaping from 3 per cent in 2013 to... https://www.scmp.com/opinion/china-opinion/article/3334948/how-china-went-generic-drug-factory-biomedicine-innovator?utm_source=rss_feed https://www.scmp.com/opinion/china-opinion/article/3334948/how-china-went-generic-drug-factory-biomedicine-innovator?utm_source=rss_feed Thu, 04 Dec 2025 01:30:09 +0000 Associated Press Associated Press The US Supreme Court on Tuesday extended an order blocking full Snap payments, amid signals that the government shutdown could soon end and food aid payments resume. The order keeps in place at least for a few more days a chaotic situation. People who depend on the Supplemental Nutrition Assistance Programme to feed their families in some states have received their full monthly allocations, while others have received nothing. The order will expire just before midnight on Thursday. The Senate has... https://www.scmp.com/news/world/united-states-canada/article/3332404/us-supreme-court-lets-trump-continue-cuts-snap-food-aid-even-shutdown-nears-end?utm_source=rss_feed https://www.scmp.com/news/world/united-states-canada/article/3332404/us-supreme-court-lets-trump-continue-cuts-snap-food-aid-even-shutdown-nears-end?utm_source=rss_feed Tue, 11 Nov 2025 23:49:26 +0000 Eric Ng,Julie Zhang Eric Ng,Julie Zhang The ferocity of China’s biopharmaceutical investment boom this year – fuelled by record-breaking licensing of commercial rights to global giants after a three-year slump – may have surprised casual observers. But according to Helen Chen, one of the most respected analysts and advisers in China’s life sciences space, the supercharged sector’s real renaissance came two years earlier. In December 2022, US drug maker MSD agreed to license global (excluding China) rights to develop and commercialise... https://www.scmp.com/business/article/3331950/six-best-how-chinas-new-biotech-vanguard-banking-billions-breakthroughs?utm_source=rss_feed https://www.scmp.com/business/article/3331950/six-best-how-chinas-new-biotech-vanguard-banking-billions-breakthroughs?utm_source=rss_feed Sat, 08 Nov 2025 03:00:14 +0000 Daniel Ren Daniel Ren Fosun Pharmaceutical, a leading healthcare group, has taken a substantial step towards introducing particle therapy systems to hospitals in mainland China, aligning with Beijing’s efforts to make advanced medical treatment accessible to cancer patients across the country. The Shanghai-based company, a subsidiary of China’s non-state-owned conglomerate Fosun International, formed a partnership with Leo Cancer Care on Thursday, pledging to distribute the UK firm’s Marie medical facilities in the... https://www.scmp.com/business/china-business/article/3331824/fosun-brings-uk-particle-therapy-mainland-china-push-advanced-cancer-care?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3331824/fosun-brings-uk-particle-therapy-mainland-china-push-advanced-cancer-care?utm_source=rss_feed Thu, 06 Nov 2025 23:30:16 +0000 Eric Ng Eric Ng Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose after the company unveiled clinical-trial data showing that its lung-cancer drug outperformed a highly effective existing treatment. The data showed that ivonescimab had “a decisive and strong positive outcome with both significant and clinically meaningful benefits”, Akeso said in a filing with the Hong Kong stock exchange on Monday. The drug, used along with... https://www.scmp.com/business/article/3329639/chinas-akeso-dubbed-biotechs-deepseek-gets-share-boost-cancer-drug-trial-data?utm_source=rss_feed https://www.scmp.com/business/article/3329639/chinas-akeso-dubbed-biotechs-deepseek-gets-share-boost-cancer-drug-trial-data?utm_source=rss_feed Mon, 20 Oct 2025 07:00:12 +0000 Resty Woro Yuniar Resty Woro Yuniar Indonesia has said that its shrimp shipments to the US can continue following stricter rules in response to a radiation scare, as business executives call for a global campaign to restore the reputation of the product and diversify the local industry’s markets apart from the world’s largest economy. The Marine Affairs and Fisheries Ministry in Jakarta said on Saturday that exports to the US, the biggest buyer of Indonesia’s shrimps, could resume for companies based on Java island and Lampung... https://www.scmp.com/week-asia/economics/article/3329023/indonesia-aims-export-shrimps-us-again-after-radiation-scare?utm_source=rss_feed https://www.scmp.com/week-asia/economics/article/3329023/indonesia-aims-export-shrimps-us-again-after-radiation-scare?utm_source=rss_feed Wed, 15 Oct 2025 05:30:08 +0000 Bloomberg Bloomberg Indonesia has halted imports of scrap metal after tracing radioactive contamination found at an industrial site and in shrimp shipments to the US to local metal processors. The suspension is effective immediately, Bara Krishna Hasibuan, an official with the government task force investigating the radiation findings, said in a text message on Thursday. Environment Minister Hanif Faisol Nurofiq said the pause aims to ensure that the local steel-recycling industry meets radiation safety standards,... https://www.scmp.com/news/asia/southeast-asia/article/3328379/indonesia-halts-scrap-metal-imports-after-shrimp-radiation-scare?utm_source=rss_feed https://www.scmp.com/news/asia/southeast-asia/article/3328379/indonesia-halts-scrap-metal-imports-after-shrimp-radiation-scare?utm_source=rss_feed Thu, 09 Oct 2025 09:20:28 +0000 Eric Ng Eric Ng Cancer screening device developer Mirxes Holding has won approval from Beijing to launch a gastric cancer test, the first blood test for the disease in China’s vast oncology diagnostics market. Its leading product, GastroClear, an in-house-developed non-invasive blood test, was approved by the National Medical Products Administration of China, the Singapore-based micro ribonucleic acid (miRNA) technology firm said in a filing to Hong Kong’s stock exchange on Thursday. “GastroClear is the world’s... https://www.scmp.com/business/article/3328316/mirxes-wins-chinas-approval-launch-groundbreaking-blood-test-gastric-cancer?utm_source=rss_feed https://www.scmp.com/business/article/3328316/mirxes-wins-chinas-approval-launch-groundbreaking-blood-test-gastric-cancer?utm_source=rss_feed Thu, 09 Oct 2025 05:03:55 +0000 Eric Ng,Julie Zhang Eric Ng,Julie Zhang When Zhao Hong, chief doctor of China’s leading cancer hospital at the Chinese Academy of Medical Sciences, told his fellow delegates at a Communist Party meeting in March that a little-known Guangzhou biotech firm’s cancer drug had beaten the world’s bestselling medicine, investors took notice. “As a long-serving front-line doctor, my most profound feeling is that China is at the best time of its biopharmaceutical sector’s development,” he told state media on the sidelines of the annual Chinese... https://www.scmp.com/business/china-business/article/3327701/chinas-biotech-renaissance-rising-drug-creation-prowess-attracts-global-notice?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3327701/chinas-biotech-renaissance-rising-drug-creation-prowess-attracts-global-notice?utm_source=rss_feed Sat, 04 Oct 2025 02:00:09 +0000 SCMP’s Asia desk SCMP’s Asia desk Indonesia is racing to contain the fallout from a radioactive contamination scare after traces of caesium-137 were detected in shipments of cloves and frozen shrimp to the United States, prompting import blocks on two major exporters and urgent clean-up efforts in an industrial zone west of Jakarta. The US Food and Drug Administration (FDA) first detected the radioactive isotope in frozen shrimp in August, followed by a second detection in cloves in late September. While both samples were below... https://www.scmp.com/week-asia/health-environment/article/3327649/indonesia-races-contain-fallout-radiation-scare-tied-us-bound-food-shipments?utm_source=rss_feed https://www.scmp.com/week-asia/health-environment/article/3327649/indonesia-races-contain-fallout-radiation-scare-tied-us-bound-food-shipments?utm_source=rss_feed Thu, 02 Oct 2025 09:20:43 +0000 Eric Ng Eric Ng Shares in Jiangsu Hengrui Pharmaceuticals, China’s largest drug maker by market value, got a boost on Thursday after it announced its fifth licensing deal of the year, widening its access to the key emerging market of India. The Shanghai-listed company, which went public in Hong Kong in May and raised HK$9.9 billion (US$1.26 billion), struck a deal with Glenmark Specialty of Mumbai-based Glenmark Pharmaceuticals, it said in a stock exchange filing late on Wednesday. The agreement was part of an... https://www.scmp.com/business/article/3326777/chinas-hengrui-gets-boost-fifth-drug-licensing-deal-year-adds-india-partner?utm_source=rss_feed https://www.scmp.com/business/article/3326777/chinas-hengrui-gets-boost-fifth-drug-licensing-deal-year-adds-india-partner?utm_source=rss_feed Thu, 25 Sep 2025 04:48:31 +0000 Agence France-Presse Agence France-Presse UK researchers said Wednesday they had slowed the progression of the fatal neural condition Huntington’s disease for the first time with a groundbreaking new gene therapy. Some patients who took part in early-stage clinical trials at University College London (UCL) saw the speed at which their condition developed reduced by 75 per cent after three years, according to uniQure, a gene therapy company based in the Netherlands and the United States. The study tested a new gene therapy, AMT-130,... https://www.scmp.com/news/world/europe/article/3326738/uk-scientists-slow-huntingtons-disease-first-time?utm_source=rss_feed https://www.scmp.com/news/world/europe/article/3326738/uk-scientists-slow-huntingtons-disease-first-time?utm_source=rss_feed Wed, 24 Sep 2025 17:15:06 +0000 Aisyah Llewellyn Aisyah Llewellyn Indonesia’s beloved Indomie instant noodles are facing renewed scrutiny after Taiwanese regulators detected trace amounts of a banned carcinogen in a popular flavour variant. Taiwan’s Food and Drug Administration (FDA) said it had found 0.1 milligrams per kilogram of ethylene oxide in the seasoning packet of the Soto Banjar Limau Kuit variety imported from Indonesia – a level deemed non-compliant under Taiwanese regulations, which prohibit any detectable presence of the chemical. “The seasoning... https://www.scmp.com/week-asia/health-environment/article/3326027/your-indomie-poisonous-carcinogen-scare-prompts-food-safety-debate?utm_source=rss_feed https://www.scmp.com/week-asia/health-environment/article/3326027/your-indomie-poisonous-carcinogen-scare-prompts-food-safety-debate?utm_source=rss_feed Fri, 19 Sep 2025 00:00:17 +0000 Alice Li Alice Li In the summer of 2015, a time when China’s pharmaceutical market was in a phase of rapid expansion, a sudden regulatory change sent tremors through the industry: drug companies would need to audit the clinical trial data for all pending applications. If withdrawn within a month of the announcement, firms could avoid penalties for submitting flawed applications, but hiding or falsifying data would court severe punishments, including multi-year filing bans. The response from the industry indicated... https://www.scmp.com/economy/china-economy/article/3324487/chinas-biotech-industry-gaining-us-can-tariffs-hold-them-back?utm_source=rss_feed https://www.scmp.com/economy/china-economy/article/3324487/chinas-biotech-industry-gaining-us-can-tariffs-hold-them-back?utm_source=rss_feed Fri, 05 Sep 2025 22:00:13 +0000 Dave Besseling Dave Besseling “An advanced test for AIDS, the deadly acquired immune deficiency syndrome, could be available in Hongkong by May,” reported the South China Morning Post on February 19, 1985. “American researchers have developed a commercial kit to detect the disease and hope to receive an official go-ahead to begin production this month. “The US Federal Drug Administration (FDA) is expected to license the test within the next two weeks, paving the way for its export abroad. The Australian Government has... https://www.scmp.com/postmag/culture/article/3324310/when-hong-kong-got-breakthrough-aids-tests-screen-blood-donors?utm_source=rss_feed https://www.scmp.com/postmag/culture/article/3324310/when-hong-kong-got-breakthrough-aids-tests-screen-blood-donors?utm_source=rss_feed Thu, 04 Sep 2025 10:15:14 +0000 Agence France-Presse Agence France-Presse US health authorities have suspended the licence for the Ixchiq vaccine against the chikungunya virus following reports of “serious adverse events”, the drug’s French maker said on Monday. Ixchiq is one of just two vaccines approved by the US Food and Drug Administration (FDA) for the mosquito-spread virus, which mainly occurs in tropical and subtropical regions but has recently been discovered in countries worldwide. French company Valneva obtained US approval for the vaccine in 2023, but... https://www.scmp.com/news/world/united-states-canada/article/3323079/chikungunya-vaccine-suspended-us-after-serious-side-effects-emerge?utm_source=rss_feed https://www.scmp.com/news/world/united-states-canada/article/3323079/chikungunya-vaccine-suspended-us-after-serious-side-effects-emerge?utm_source=rss_feed Mon, 25 Aug 2025 10:11:09 +0000 Hannah Wang Hannah Wang Alibaba Group Holding’s research arm Damo Academy and Beijing United Family Hospital (BJU), the flagship facility of the private United Family Healthcare network in mainland China, have formed a strategic partnership to use AI in complicated cancer diagnosis and treatment. The collaboration will leverage Damo Academy’s medical artificial intelligence system, called “One Sweep Multi-Check”, as part of efforts to offer multi-disease AI screening services to the public, according to Monday’s... https://www.scmp.com/tech/big-tech/article/3320795/alibaba-beijing-united-family-hospital-partner-use-ai-cancer-diagnosis-treatment?utm_source=rss_feed https://www.scmp.com/tech/big-tech/article/3320795/alibaba-beijing-united-family-hospital-partner-use-ai-cancer-diagnosis-treatment?utm_source=rss_feed Tue, 05 Aug 2025 09:00:07 +0000 Eric Ng Eric Ng A pair of Hong Kong-listed mainland Chinese biotechnology firms are poised to turn a profit this year as their revenue from novel drugs finally outstrips costs related to research and development and marketing, according to analysts. “Chinese biotechs have matured significantly and are creating value for Chinese patients and government payers,” said Tony Ren, head of Asia healthcare research at Macquarie Capital, in a report on July 16. “[Some will] likely turn profitable soon and no longer rely... https://www.scmp.com/business/article/3320623/innovent-beone-are-poised-profits-2025-milestone-chinese-biotech-start-ups?utm_source=rss_feed https://www.scmp.com/business/article/3320623/innovent-beone-are-poised-profits-2025-milestone-chinese-biotech-start-ups?utm_source=rss_feed Mon, 04 Aug 2025 02:19:01 +0000 Holly Chik Holly Chik A Chinese analysis of prescription anti-obesity medications has added to evidence that people who use popular GLP-1 drugs such as Ozempic to shed pounds face the prospect of “significant” weight rebound once they stop using them – challenges similar to those presented by more traditional slimming strategies. Patients saw “significant weight” return eight weeks after anti-obesity medications (AOMs) were stopped, which continued after 20 weeks, the team from Peking University People’s Hospital... https://www.scmp.com/news/china/science/article/3319174/china-glp-1-drug-study-suggests-slim-chance-weight-stays-after-treatment?utm_source=rss_feed https://www.scmp.com/news/china/science/article/3319174/china-glp-1-drug-study-suggests-slim-chance-weight-stays-after-treatment?utm_source=rss_feed Wed, 23 Jul 2025 10:00:15 +0000 Anthea Rowan Anthea Rowan Dr Sue Jamieson remembers when the famous Women’s Health Initiative (WHI) study on hormone replacement therapy, or HRT, was published. “I was in New Mexico on holiday and caught this on the news,” says Jamieson, a Hong Kong-based specialist in integrative and functional medicine. “I was so horrified that I might be endangering my patients’ health. I sent all those on hormones an email asking them to stop it.” The study, published more than 20 years ago, was hugely damning of HRT, suggesting it... https://www.scmp.com/lifestyle/health-wellness/article/3318566/anti-ageing-benefits-hrt-collagen-production-better-brain-and-heart-health?utm_source=rss_feed https://www.scmp.com/lifestyle/health-wellness/article/3318566/anti-ageing-benefits-hrt-collagen-production-better-brain-and-heart-health?utm_source=rss_feed Sat, 19 Jul 2025 00:15:08 +0000 SCMP Editorial SCMP Editorial Hong Kong has good reason to aspire to its own internationally recognised regime for approving pharmaceutical drugs. Intense global demand for Covid-19 vaccines remains fresh in the memory. The city also happens to rank No 2, behind only New York, as a market for biomedical and pharmaceutical companies to raise capital. To realise this goal, developing independent clinical trial capacity and a regulatory framework comparable with the US Food and Drug Administration would go a long way. It would... https://www.scmp.com/opinion/comment/article/3316336/new-drug-approval-system-takes-hong-kong-closer-biomedical-hub-goal?utm_source=rss_feed https://www.scmp.com/opinion/comment/article/3316336/new-drug-approval-system-takes-hong-kong-closer-biomedical-hub-goal?utm_source=rss_feed Mon, 30 Jun 2025 22:45:08 +0000 Coco Feng Coco Feng Alibaba Group Holding unveiled what it says is the world’s first artificial intelligence (AI) model to detect gastric cancer, even in early stages, by scanning computed tomography (CT) images. Known as Grape – a name derived from “gastric cancer risk assessment procedure” – the system is a deep-learning framework that can analyse three-dimensional CT scans to detect and segment gastric cancer, also known as stomach cancer. It was co-developed by Alibaba’s Damo Academy and the Zhejiang Cancer... https://www.scmp.com/tech/article/3315931/alibaba-touts-worlds-first-ai-model-detect-stomach-cancer-even-early-stages?utm_source=rss_feed https://www.scmp.com/tech/article/3315931/alibaba-touts-worlds-first-ai-model-detect-stomach-cancer-even-early-stages?utm_source=rss_feed Thu, 26 Jun 2025 10:00:16 +0000